Oculus Innovative Sciences (OCLS) Granted FDA 510(K) Approval for Microcyn Plus Wound Care Solution
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Oculus Innovative Sciences (NASDAQ: OCLS) was granted FDA 510 (k) okay for its Microcyn Plus Wound Care Solution.
|Device Classification Name||Dressing, Wound, Drug|
|Device Name||Microcyn Plus Wound Care Solution|
|Applicant Contact||Brian W. Martin|
|Correspodent Contact||Brian W. Martin|
|Classification Product Code|
|Decision||Substantially Equivalent (SESE)|
|510k Review Panel||General & Plastic Surgery|
|Reviewed By Third Party||No|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Options with increasing volume: FNSR P GPL QCOM RAD
- Stocks with Implied Volatility Movement
- Alphabet (GOOGL) January weekly volatility increases into Q4 and outlook
Create E-mail Alert Related CategoriesFDA, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!